Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Launches Phase III Trial For NSCLC Candidate

Apr 11 2008

Related Content

Ovarian Cancer Claim For Antisoma Oncologic On Back Burner

Jul 12 2007

Antisoma: Novartis Will Include Non-Squamous NSCLC Patients In Phase III ASA404 Trial

Nov 21 2007

Novartis Looks To Bring First-In-Class Vascular Disrupting Agent To Market

Apr 19 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window